In Q1–Q3 2022, the sales of veterinary drugs in the Russian retail market were 16.8 billion RUB (retail prices, VAT included), down 3.6% from Q1–Q3 2021. Even the actively growing e-commerce with its growth rates of 67% could not save the situation. In physical terms, the sales were 107.5 million minimum dosage units (MDU), down 20%. The online sales went up 33%, while the offline sales fell 21%.

From January to September 2022, Russia imported 28.1 billion rubles’ worth of veterinary drugs (customs clearance and VAT included), 5.1% up from the same period last year. In physical terms, the growth rate was 7.6%, with 24.4 million packages imported. As for feed supplements, the growth rates in both monetary and physical terms are negative: –2.3% in rubles and –12.1% in tons. The import of feed supplements in January–September was 110,300 tons worth around 31.8 billion rubles.

In January–September 2022, Russian manufacturers produced 528.1 billion rubles’ worth of ready-made drugs (manufacturer’s prices, VAT included), up 22% from the same period in 2021. In physical terms, the production volume was 3.09 billion packages, up 3.6% from January–September 2021. If calculated in minimum dosage units (MDU), the volume was 59 billion MDUs, 2.6% up from January–September 2021.

From January to September 2022, Russia imported 607.7 billion rubles’ worth of ready-made pharmaceutical drugs (customs clearance and VAT included, imports from the EEU excluded), up 9.4% from the same period in 2021. The import of bulk drugs grew 22.4%. In physical terms, the import of ready-made drugs was 1.24 billion packages, or 23.9 minimum dosage units (MDU), up 6.9% in packages and 8.6% in MDUs. As for bulk drugs, the growth rate was 38%, with around 1 billion MDUs imported.

From January to September 2022, Russia imported 607.7 billion rubles’ worth of ready-made pharmaceutical drugs (customs clearance and VAT included, imports from the EEU excluded), up 9.4% from the same period in 2021. The import of bulk drugs grew 22.4%. In physical terms, the import of ready-made drugs was 1.24 billion packages, or 23.9 minimum dosage units (MDU), up 6.9% in packages and 8.6% in MDUs. As for bulk drugs, the growth rate was 38%, with around 1 billion MDUs imported.

In January–September 2022, Russia imported 149.7 billion rubles’ worth of APIs (customs clearance and VAT included), up 3.1% from the same period last year. This is one of the lowest growth rates in the past 12 years—a lower growth rate, 1.3%, was seen only in 2016. In physical terms, the growth rate hit a record high—25%, with 15,000 tons of APIs imported.

More Than 55% of Russian Doctors Think License Renewal Exams Are Average and Formal in Nature.